Lantus and Methylin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Methylin (methylphenidate hydrochloride). Common drug interactions include sleep apnoea syndrome among females and fungal test positive among males.

The phase IV clinical study analyzes what interactions people have when they take Lantus and Methylin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is Methylin?

Methylin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,116 Methylin users. Check the latest studies of Methylin.

On Jul, 10, 2026

14 people who take Lantus and Methylin together, and have interactions are studied.

What are the common drug interactions of Lantus and Methylin, by gender? *:

female:

Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Blood pressure increased
Liver injury
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Vomiting
Abdominal discomfort
Blood glucose decreased
Drug ineffective
Drug intolerance (drug sensitivity)

male:

Fungal test positive
Nephrolithiasis (calculi in the kidneys)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Skin lesion
Urinary tract infection

What are the common drug interactions of Lantus and Methylin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Dyspepsia (indigestion)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

Drug ineffective
Skin lesion

60+:

Blood glucose decreased
Blood pressure increased
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
Sepsis (a severe blood infection that can lead to organ failure and death)
Urinary tract infection
Chronic kidney disease
Dysphagia (a condition in which swallowing is difficult or painful)
Fungal test positive
Hypoglycaemia (deficiency of glucose in the bloodstream)
Liver injury

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 71.43%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 42.86%
Pain: 3 people, 21.43%
Weakness: 1 person, 7.14%
Type 2 Diabetes: 1 person, 7.14%
Thyroid Diseases: 1 person, 7.14%
Prostate Cancer: 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Gout (uric acid crystals building up in the body): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and Methylin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously